About
Profile
Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With more than 19,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 milli
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
HSIC
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- Henry Schein Non-GAAP EPS of $1.21 misses by $0.02, revenue of $3.06B misses by $30M
- Henry Schein Q1 2023 Earnings Preview
- Henry Schein acquires Regional Health Care Group
- Henry Schein to acquire S.I.N. Implant System, Brazil
- Henry Schein issues 2023 EPS guidance that comes in above consensus
- Henry Schein Non-GAAP EPS of $1.21 misses by $0.01, revenue of $3.4B beats by $30M, Introduces guidance for 2023
- Henry Schein Q4 2022 Earnings Preview
- Henry Schein authorizes $400M buyback
- Henry Schein unit acquires majority interest in Unitas PPO Solutions
- Henry Schein invests and forms strategic partnership with Biotech Dental
- Henry Schein receives subpoena for documents related to former veterinary division
- Henry Schein Non-GAAP EPS of $1.15 beats by $0.01, revenue of $3.1B misses by $90M
- Henry Schein Q3 2022 Earnings Preview
- Henry Schein acquires Midway Dental Supply; terms undisclosed
- Stable yet sluggish domestic demand could impact dental stocks - Baird
- Henry Schein announces $400M increase to stock buyback plan
- Henry Schein gets upgrade at UBS on potential margin expansion
- Henry Schein Non-GAAP EPS of $1.16 in-line, revenue of $3B misses by $120M
- Henry Schein Q2 2022 Earnings Preview
- Henry Schein, Envista cut at Baird after dental survey suggests drop in patient volume
